查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1881442

連續性腎臟替代療法市場－全球產業規模、佔有率、趨勢、機會和預測，按產品、治療方式、最終用戶、地區和競爭格局分類，2020-2030年預測

Continuous Renal Replacement Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Modality, By End User Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 186 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球連續性腎臟替代療法市場規模為13.2億美元，預計2030年將以8.91%的複合年成長率成長至22億美元。連續性腎臟替代療法（CRRT）是一種體外血液淨化技術，主要用於治療重症監護病房中出現急性腎損傷或嚴重體液超負荷的重症患者。該市場的成長主要受以下因素驅動：全球急性腎損傷發病率不斷上升、老年人口不斷成長（老年人本身就更容易出現腎臟併發症）以及CRRT系統的技術不斷進步。

市場概覽
預測期 2026-2030
2024年市場規模 13.2億美元
2030年市場規模 22億美元
2025-2030年複合年成長率 8.91%
成長最快的細分市場 連續性靜脈-靜脈血液透析濾過（CVVHDF）
最大的市場 北美洲

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球連續性腎臟替代療法市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品分類（透析液和置換液、一次性用品、血液濾過器、血路輸液器和導管、其他一次性用品、CRRT系統）
    • 依治療方式（連續性靜脈-靜脈血液濾過（CVVH）、連續性靜脈-靜脈血液透析濾過（CVVHDF）、連續性靜脈-靜脈血液透析（CVVHD）、慢速連續超濾（SCUF））
    • 按最終使用者（醫院和診所、門診手術護理、其他）
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美連續性腎臟替代療法市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲連續性腎臟替代療法市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區連續性腎臟替代療法市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲連續性腎臟替代療法市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲連續性腎臟替代療法市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購（如有）
  • 產品發布（如有）
  • 最新進展

第13章：全球連續性腎臟替代療法市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Baxter International, Inc
  • Fresenius Ag & Co.
  • Nikkiso Co., Ltd
  • Braun Melsungen Ag
  • Medtronic Plc
  • Asahi Kasei Corporation
  • Toray Medical Co., Ltd.
  • Informed SA
  • Nipro Corporation
  • Medica SPA

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 21070

The Global Continuous Renal Replacement Therapy Market, valued at USD 1.32 Billion in 2024, is projected to experience a CAGR of 8.91% to reach USD 2.20 Billion by 2030. Continuous Renal Replacement Therapy (CRRT) represents a continuous extracorporeal blood purification technique employed for critically ill patients experiencing acute kidney injury or severe fluid overload, primarily within intensive care settings. The market's expansion is fundamentally driven by the escalating global incidence of acute kidney injury, the increasing geriatric population which inherently presents a higher predisposition to renal complications, and ongoing technological advancements in CRRT systems.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.32 Billion
Market Size 2030USD 2.20 Billion
CAGR 2025-20308.91%
Fastest Growing SegmentContinuous venovenous hemodiafiltration (CVVHDF)
Largest MarketNorth America

Key Market Drivers

The Global Continuous Renal Replacement Therapy market is significantly influenced by the increasing incidence of acute kidney injury and chronic kidney disease. These conditions frequently necessitate advanced renal support, directly expanding the patient pool eligible for CRRT. The widespread nature of renal ailments is underscored by recent findings, where according to EurekAlert! , in October 2025, reporting on the Global Burden of Disease Study 2023, kidney dysfunction was identified among the top ten risk factors for global health loss in 2023. This pervasive health challenge creates a continuous and growing demand for effective therapeutic interventions like CRRT.

Key Market Challenges

The substantial cost associated with Continuous Renal Replacement Therapy equipment and disposable sets represents a significant impediment to market expansion. This financial burden directly affects healthcare systems globally, particularly those operating under budget constraints, by limiting their capacity for equipment acquisition and sustained operational expenses. According to a study published in *Critical Care Explorations* in June 2023, the daily cost of CRRT was estimated to be approximately $872 from a U. S. healthcare payer perspective, indicating a considerable financial commitment for healthcare facilities.

Key Market Trends

The integration of artificial intelligence (AI) is significantly enhancing the precision and operational efficiency of Continuous Renal Replacement Therapy. AI algorithms can analyze extensive patient data to predict responses, optimize fluid balance, and automate medication dosing, thereby minimizing human error and supporting more consistent, tailored treatments in critical care. Fresenius Medical Care, in October 2023, announced its strategic initiative to develop AI models utilizing anonymized data from over 540,000 dialysis patients. This endeavor is aimed at refining various aspects of dialysis therapies, including the optimization of erythropoietin stimulating agents and iron therapies. Such advancements are critical for transitioning from reactive interventions to proactive, data-driven patient management. While the practical application of AI in CRRT is still developing, research into its potential to enhance CRRT delivery has seen substantial growth in recent years, highlighting its recognized importance within the industry.

Key Market Players

  • Baxter International, Inc
  • Fresenius Ag & Co.
  • Nikkiso Co., Ltd
  • Braun Melsungen Ag
  • Medtronic Plc
  • Asahi Kasei Corporation
  • Toray Medical Co., Ltd.
  • Informed SA
  • Nipro Corporation
  • Medica SPA

Report Scope:

In this report, the Global Continuous Renal Replacement Therapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Continuous Renal Replacement Therapy Market, By Product:

  • Dialysates and Replacement Fluids
  • Disposables
  • Hemofilters
  • Bloodline Sets & Tubes
  • Other Disposables
  • CRRT Systems

Continuous Renal Replacement Therapy Market, By Modality:

  • Continuous venovenous hemofiltration (CVVH)
  • Continuous venovenous hemodiafiltration (CVVHDF)
  • Continuous venovenous hemodialysis (CVVHD)
  • Slow continuous ultrafiltration (SCUF)

Continuous Renal Replacement Therapy Market, By End User:

  • Hospital & Clinics
  • Ambulatory Surgical care
  • Others

Continuous Renal Replacement Therapy Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Continuous Renal Replacement Therapy Market.

Available Customizations:

Global Continuous Renal Replacement Therapy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Continuous Renal Replacement Therapy Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Dialysates and Replacement Fluids, Disposables, Hemofilters, Bloodline Sets & Tubes, Other Disposables, CRRT Systems)
    • 5.2.2. By Modality (Continuous venovenous hemofiltration (CVVH), Continuous venovenous hemodiafiltration (CVVHDF), Continuous venovenous hemodialysis (CVVHD), Slow continuous ultrafiltration (SCUF))
    • 5.2.3. By End User (Hospital & Clinics, Ambulatory Surgical care, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Continuous Renal Replacement Therapy Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Modality
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Continuous Renal Replacement Therapy Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Modality
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Continuous Renal Replacement Therapy Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Modality
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Continuous Renal Replacement Therapy Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Modality
        • 6.3.3.2.3. By End User

7. Europe Continuous Renal Replacement Therapy Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Modality
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Continuous Renal Replacement Therapy Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Modality
        • 7.3.1.2.3. By End User
    • 7.3.2. France Continuous Renal Replacement Therapy Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Modality
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Continuous Renal Replacement Therapy Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Modality
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Continuous Renal Replacement Therapy Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Modality
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Continuous Renal Replacement Therapy Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Modality
        • 7.3.5.2.3. By End User

8. Asia Pacific Continuous Renal Replacement Therapy Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Modality
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Continuous Renal Replacement Therapy Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Modality
        • 8.3.1.2.3. By End User
    • 8.3.2. India Continuous Renal Replacement Therapy Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Modality
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Continuous Renal Replacement Therapy Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Modality
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Continuous Renal Replacement Therapy Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Modality
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Continuous Renal Replacement Therapy Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Modality
        • 8.3.5.2.3. By End User

9. Middle East & Africa Continuous Renal Replacement Therapy Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Modality
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Continuous Renal Replacement Therapy Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Modality
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Continuous Renal Replacement Therapy Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Modality
        • 9.3.2.2.3. By End User
    • 9.3.3. South Africa Continuous Renal Replacement Therapy Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Modality
        • 9.3.3.2.3. By End User

10. South America Continuous Renal Replacement Therapy Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Modality
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Continuous Renal Replacement Therapy Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Modality
        • 10.3.1.2.3. By End User
    • 10.3.2. Colombia Continuous Renal Replacement Therapy Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Modality
        • 10.3.2.2.3. By End User
    • 10.3.3. Argentina Continuous Renal Replacement Therapy Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Modality
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Continuous Renal Replacement Therapy Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Baxter International, Inc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Fresenius Ag & Co.
  • 15.3. Nikkiso Co., Ltd
  • 15.4. Braun Melsungen Ag
  • 15.5. Medtronic Plc
  • 15.6. Asahi Kasei Corporation
  • 15.7. Toray Medical Co., Ltd.
  • 15.8. Informed SA
  • 15.9. Nipro Corporation
  • 15.10. Medica SPA

16. Strategic Recommendations

17. About Us & Disclaimer